Advertisement

Epidermal Equivalent (EE) Potency Assay

  • Susan Gibbs
  • Sander W. Spiekstra
Chapter

Abstract

The epidermal equivalent (EE) potency assay is aimed at ranking sensitizing compounds according to their potency (extreme, strong, moderate and weak sensitizing potency) with the aid of a reconstructed human epidermal equivalent. The EE potency assay is based on our understanding from clinical observations that sensitizer potency is directly related to the irritant potency of the chemical. The primary readout is the chemical concentration, which reduces cell viability (as assessed by MTT assay) by 50% (EC50 value). Additional readouts are the chemical concentration which results in a twofold increase in IL-1alpha or IL-18 release. The lower the EC50 value, IL-1alpha (SI-2) or IL-18 (SI-2), the greater the sensitizer potency. Commercially available EE models can be used. The major advantage in using EE is that the chemical exposure mimics human exposure (topical application) and therefore overcomes drawbacks of traditional submerged culture, including chemical solubility and stability in culture medium. A pre-validation study with 4 laboratories and 13 coded chemicals succeeded in ranking sensitizers according to their potency and showed good correlation with human DSA05 and NOEL as well as animal LLNA data. Currently the EE potency assay is undergoing further technology transfer to naive partners in preparation for further validation in a ring study including America, Asia and Europe. Current results, limitations, critical steps in the protocol, correlation to human and animal data, challenges and opportunities are extensively described in this manuscript.

References

  1. 1.
    dos Santos GG, Spiekstra SW, Sampat-Sardjoepersad SC, Reinders J, Scheper RJ, Gibbs S. A potential in vitro epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro. 2011;25:347–57.CrossRefPubMedGoogle Scholar
  2. 2.
    Spiekstra SW, dos Santos GG, Scheper RJ, Gibbs S. Potential method to determine irritant potency in vitro - comparison of two reconstructed epidermal culture models with different barrier competency. Toxicol In Vitro. 2009;23:349–55.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Teunis MA, Spiekstra SW, Smits M, Adriaens E, Eltze T, Galbiati V, Krul C, Landsiedel R, Pieters R, Reinders J, Roggen E, Corsini E, Gibbs S. International ring trial of the epidermal equivalent sensitizer potency assay: reproducibility and predictive-capacity. ALTEX. 2014;31:251–68.CrossRefPubMedGoogle Scholar
  4. 4.
    Agner T, Johansen JD, Overgaard L, Volund A, Basketter D, Menne T. Combined effects of irritants and allergens. Synergistic effects of nickel and sodium lauryl sulfate in nickel- sensitized individuals. Contact Dermatitis. 2002;47:21–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Basketter DA, Kan-King-Yu D, Dierkes P, Jowsey IR. Does irritation potency contribute to the skin sensitization potency of contact allergens? Cutan Ocul Toxicol. 2007;26:279–86.CrossRefPubMedGoogle Scholar
  6. 6.
    Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I, Denis A, Nicolas JF, Hennino A. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol. 2007;127:1430–5.CrossRefPubMedGoogle Scholar
  7. 7.
    McLelland J, Shuster S, Matthews JN. 'Irritants' increase the response to an allergen in allergic contact dermatitis. Arch Dermatol. 1991;127:1016–101.CrossRefPubMedGoogle Scholar
  8. 8.
    Edele F, Esser PR, Lass C, Laszczyk MN, Oswald E, Struh CM, Rensing-Ehl A, Martin SF. Innate and adaptive immune responses in allergic contact dermatitis and autoimmune skin diseases. Inflamm Allergy Drug Targets. 2007;6:236–44.CrossRefPubMedGoogle Scholar
  9. 9.
    Martin SF, Jakob T. From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Clin Immunol. 2008;8:289–93.CrossRefPubMedGoogle Scholar
  10. 10.
    Martin SF, Esser PR, Weber FC, Jakob T, Freudenberg MA, Schmidt M, Goebeler M. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy. 2011;66:1152–63.CrossRefPubMedGoogle Scholar
  11. 11.
    Antonopoulos C, Cumberbatch M, Mee JB, Dearman RJ, Wei XQ, Liew FY, Kimber I, Groves RW. IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol. 2008;83:361–7.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Corsini E, Galbiati V, Mitjans M, Galli CL, Marinovich M. NCTC 2544 and IL-18 production: a tool for the identification of contact allergens. Toxicol In Vitro. 2013;27:1127–34.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology. 2001;102:323–30.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88–9.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fentem JH, Archer GE, Balls M, Botham PA, Curren RD, Earl LK, Esdaile DJ, Holzhutter HG, Liebsch M. The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the management team. Toxicol In Vitro. 1998;12:483–524.CrossRefPubMedGoogle Scholar
  16. 16.
    Spielmann H, Hoffmann S, Liebsch M, Botham P, Fentem JH, Eskes C, Roguet R, Cotovio J, Cole T, Worth A, Heylings J, Jones P, Robles C, Kandarova H, Gamer A, Remmele M, Curren R, Raabe H, Cockshott A, Gerner I, Zuang V. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the skin integrity function test. Altern Lab Anim. 2007;35:559–601.PubMedGoogle Scholar
  17. 17.
    Gibbs S, Corsini E, Spiekstra SW, Galbiati V, Fuchs HW, Degeorge G, Troese M, Hayden P, Deng W, Roggen E. An epidermal equivalent assay for identification and ranking potency of contact sensitizers. Toxicol Appl Pharmacol. 2013;272:529–41.CrossRefPubMedGoogle Scholar
  18. 18.
    Gibbs S, Spiekstra S, Corsini E, McLeod J, Reinders J. Dendritic cell migration assay: a potential prediction model for identification of contact allergens. Toxicol In Vitro. 2013;27:1170–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Corsini E, Roggen EL. Immunotoxicology: opportunities for non-animal test development. Altern Lab Anim. 2009;37:387–97.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Galbiati V, Mitjans M, Lucchi L, Viviani B, Galli CL, Marinovich M, Corsini E. Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. Toxicol In Vitro. 2011;25:724–32.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Rovida C, Martin SF, Vivier M, Weltzien HU, Roggen E. Advanced tests for skin and respiratory sensitization assessment. ALTEX. 2013;30:231–52.CrossRefPubMedGoogle Scholar
  22. 22.
    van Och FM, van LH, Van Wolfswinkel JC, Machielsen AJ, Vandebriel RJ. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line. Toxicology. 2005;210:95–109.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Teunis M, Corsini E, Smits M, Madsen CB, Eltze T, Ezendam J, Galbiati V, Gremmer E, Krul C, Landin A, Landsiedel R, Pieters R, Rasmussen TF, Reinders J, Roggen E, Spiekstra S, Gibbs S. Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro. 2013;27:1135–50.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Reisinger K, Hoffmann S, Alepee N, Ashikaga T, Barroso J, Elcombe C, Gellatly N, Galbiati V, Gibbs S, Groux H, Hibatallah J, Keller D, Kern P, Klaric M, Kolle S, Kuehnl J, Lambrechts N, Lindstedt M, Millet M, Martinozzi-Teissier S, Natsch A, Petersohn D, Pike I, Sakaguchi H, Schepky A, Tailhardat M, Templier M, van Vliet E, Maxwell G. Systematic evaluation of non-animal test methods for skin sensitisation safety assessment. Toxicol In Vitro. 2014;29:259–70.CrossRefGoogle Scholar
  25. 25.
    Gerberick GF, Ryan CA, Kern PS, Schlatter H, Dearman RJ, Kimber I, Patlewicz GY, Basketter DA. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis. 2005;16:157–202.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Gerberick GF, House RV, Fletcher ER, Ryan CA. Examination of the local lymph node assay for use in contact sensitization risk assessment. Fundam Appl Toxicol. 1992;19:438–45.CrossRefPubMedGoogle Scholar
  27. 27.
    Loveless SE, Ladics GS, Gerberick GF, Ryan CA, Basketter DA, Scholes EW, House RV, Hilton J, Dearman RJ, Kimber I. Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology. 1996;108:141–52.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Basketter DA, Gerberick F, Kimber I. The local lymph node assay and the assessment of relative potency: status of validation. Contact Dermatitis. 2007;57:70–5.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Basketter DA, Scholes EW. Comparison of the local lymph node assay with the guinea-pig maximization test for the detection of a range of contact allergens. Food Chem Toxicol. 1992;30:65–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Basketter DA, Alepee N, Ashikaga T, Barroso J, Gilmour N, Goebel C, Hibatallah J, Hoffmann S, Kern P, Martinozzi-Teissier S, Maxwell G, Reisinger K, Sakaguchi H, Schepky A, Tailhardat M, Templier M. Categorization of chemicals according to their relative human skin sensitizing potency. Dermatitis. 2014;25:11–21.CrossRefPubMedGoogle Scholar
  31. 31.
    Betts CJ, Dearman RJ, Heylings JR, Kimber I, Basketter DA. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience. Contact Dermatitis. 2006;55:140–7.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Friedmann PS, Moss C, Shuster S, Simpson JM. Quantitation of sensitization and responsiveness to dinitrochlorobenzene in normal subjects. Br J Dermatol. 1983;109(Suppl 25):86–8.PubMedPubMedCentralGoogle Scholar
  33. 33.
    NTP. Assessment of contact hypersensitivity to Dinitrochlorobenzene, potassium dichromate and methyl salicylate in BALB16 female mice. Research Triangle Park, NC: National Institute of Environmental Health Sciences Report; 1997.Google Scholar
  34. 34.
    Rees JL, Friedmann PS, Matthews JN. Sex differences in susceptibility to development of contact hypersensitivity to dinitrochlorobenzene (DNCB). Br J Dermatol. 1989;120:371–4.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Kimber I, Hilton J, Dearman RJ, Gerberick GF, Ryan CA, Basketter DA, Scholes EW, Ladics GS, Loveless SE, House RV. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology. 1995;103:63–73.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Basketter DA, Kimber I. Predictive testing in contact allergy: facts and future. Allergy. 2001;56:937–43.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Basketter DA, Clapp C, Jefferies D, Safford B, Ryan CA, Gerberick F, Dearman RJ, Kimber I. Predictive identification of human skin sensitization thresholds. Contact Dermatitis. 2005;53:260–7.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Kimber I, Hilton J, Botham PA, Basketter DA, Scholes EW, Miller K, Robbins MC, Harrison PT, Gray TJ, Waite SJ. The murine local lymph node assay: results of an inter-laboratory trial. Toxicol Lett. 1991;55:203–13.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Kligman AM. The identification of contact allergens by human assay. II. Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol. 1966;47:375–92.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Kligman AM. The identification of contact allergens by human assay. 3. The maximization test: a procedure for screening and rating contact sensitizers. J. Invest Dermatol. 1966;47:393–409.CrossRefGoogle Scholar
  41. 41.
    Ryan CA, Gerberick GF, Cruse LW, Basketter DA, Lea L, Blaikie L, Dearman RJ, Warbrick EV, Kimber I. Activity of human contact allergens in the murine local lymph node assay. Contact Dermatitis. 2000;43:95–102.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Ryan CA, Cruse LW, Skinner RA, Dearman RJ, Kimber I, Gerberick GF. Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Food Chem Toxicol. 2002;40:1719–25.CrossRefPubMedGoogle Scholar
  43. 43.
    Marzulli FN, Maibach HI. The use of graded concentrations in studying skin sensitizers: experimental contact sensitization in man. Food Cosmet Toxicol. 1974;12:219–27.CrossRefPubMedGoogle Scholar
  44. 44.
    Basketter DA, Scholes EW, Kimber I. The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test. Food Chem Toxicol. 1994;32:543–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Basketter DA, Gerberick GF, Kimber I, Loveless SE. The local lymph node assay: a viable alternative to currently accepted skin sensitization tests. Food Chem Toxicol. 1996;34:985–97.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Danneman PJ, Booman KA, Dorsky J, Kohrman KA, Rothenstein AS, Sedlak RI, Steltenkamp RJ, Thompson GR. Cinnamic aldehyde: a survey of consumer patch-test sensitization. Food Chem Toxicol. 1983;21:721–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Kimber I, Hilton J, Weisenberger C. The murine local lymph node assay for identification of contact allergens: a preliminary evaluation of in situ measurement of lymphocyte proliferation. Contact Dermatitis. 1989;21:215–20.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Opdyke DL. Monographs on fragrance raw materials. Food Cosmet Toxicol. 1979;17:241–75.CrossRefPubMedGoogle Scholar
  49. 49.
    RIFM. In: NICEATM, editor. Data submission to NICEATM. Woodcliff Lake, NJ: RIFM; 2007.Google Scholar
  50. 50.
    Warbrick EV, Dearman RJ, Lea LJ, Basketter DA, Kimber I. Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations. J Appl Toxicol. 1999;19:255–60.CrossRefPubMedGoogle Scholar
  51. 51.
    White JM, Kullavanijaya P, Duangdeeden I, Zazzeroni R, Gilmour NJ, Basketter DA, McFadden JP. p-Phenylenediamine allergy: the role of Bandrowski's base. Clin Exp Allergy. 2006;36:1289–93.CrossRefPubMedGoogle Scholar
  52. 52.
    Wright ZM, Basketter PA, Blaikie L, Cooper KJ, Warbrick EV, Dearman RJ, Kimber I. Vehicle effects on skin sensitizing potency of four chemicals: assessment using the local lymph node assay. Int J Cosmet Sci. 2001;23:75–83.CrossRefPubMedGoogle Scholar
  53. 53.
    Basketter DA, Kimber I. Assessing the potency of respiratory allergens: uncertainties and challenges. Regul Toxicol Pharmacol. 2011;61(3):365–72. doi: 10.1016/j.yrtph.2011.10.001.CrossRefPubMedGoogle Scholar
  54. 54.
    Basketter DA, Evans P, Gerberick GF, Kimber I. Factors affecting thresholds in allergic contact dermatitis: safety and regulatory considerations. Contact Dermatitis. 2002;47:1–6.CrossRefPubMedGoogle Scholar
  55. 55.
    Basketter DA, Cadby P. Reproducible prediction of contact allergenic potency using the local lymph node assay. Contact Dermatitis. 2004;50:15–7.CrossRefPubMedGoogle Scholar
  56. 56.
    Steltenkamp RJ, Booman KA, Dorsky J, King TO, Rothenstein AS, Schwoepp EA, Sedlak RI, Smith TH, Thompson GR. Cinnamic alcohol: a survey of consumer patch-test sensitization. Food Cosmet Toxicol. 1980;18:419–24.CrossRefPubMedGoogle Scholar
  57. 57.
    Ashby J, Basketter DA, Paton D, Kimber I. Structure activity relationships in skin sensitization using the murine local lymph node assay. Toxicology. 1995;103:177–94.CrossRefPubMedGoogle Scholar
  58. 58.
    Lalko J, Isola D, Api AM. Ethanol and diethyl phthalate: vehicle effects in the local lymph node assay. Int J Toxicol. 2004;23:171–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Kimber I, Weisenberger C. Anamnestic responses to contact allergens: application in the murine local lymph node assay. J Appl Toxicol. 1991;11:129–33.CrossRefPubMedGoogle Scholar
  60. 60.
    Basketter DA, Selbie E, Scholes EW, Lees D, Kimber I, Botham PA. Results with OECD recommended positive control sensitizers in the maximization, Buehler and local lymph node assays. Food Chem Toxicol. 1993;31:63–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Scholes EW, Basketter DA, Sarll AE, Kimber I, Evans CD, Miller K, Robbins MC, Harrison PT, Waite SJ. The local lymph node assay: results of a final inter-laboratory validation under field conditions. J.Appl. Toxicology. 1992;12:217–22.Google Scholar
  62. 62.
    Basketter DA, Scholes EW, Wahlkvist H, Montelius J. An evaluation of the suitability of benzocaine as a positive control skin sensitizer. Contact Dermatitis. 1995;33:28–32.CrossRefPubMedGoogle Scholar
  63. 63.
    Griem P, Goebel C, Scheffler H. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data. Regul Toxicol Pharmacol. 2003;38:269–90.CrossRefPubMedGoogle Scholar
  64. 64.
    van Och FM, Slob W, de Jong WH, Vandebriel RJ, van LH. A quantitative method for assessing the sensitizing potency of low molecular weight chemicals using a local lymph node assay: employment of a regression method that includes determination of the uncertainty margins. Toxicology. 2000;146:49–59.CrossRefPubMedGoogle Scholar
  65. 65.
    Jordan WP Jr, King SE. Delayed hypersensitivity in females. The development of allergic contact dermatitis in females during the comparison of two predictive patch tests. Contact Dermatitis. 1977;3:19–26.CrossRefPubMedGoogle Scholar
  66. 66.
    Elahi EN, Wright Z, Hinselwood D, Hotchkiss SA, Basketter DA, Pease CK. Protein binding and metabolism influence the relative skin sensitization potential of cinnamic compounds. Chem Res Toxicol. 2004;17:301–10.CrossRefPubMedGoogle Scholar
  67. 67.
    Basketter DA, Lea LJ, Dickens A, Briggs D, Pate I, Dearman RJ, Kimber I. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J Appl Toxicol. 1999;19:261–6.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Dearman RJ, Wright ZM, Basketter DA, Ryan CA, Gerberick GF, Kimber I. The suitability of hexyl cinnamic aldehyde as a calibrant for the murine local lymph node assay. Contact Dermatitis. 2001;44:357–61.CrossRefPubMedGoogle Scholar
  69. 69.
    Gamer AO, Nies E, Vohr HW. Local lymph node assay (LLNA): comparison of different protocols by testing skin-sensitizing epoxy resin system components. Regul Toxicol Pharmacol. 2008;52:290–8.CrossRefPubMedGoogle Scholar
  70. 70.
    Basketter DA, Smith Pease CK, Patlewicz GY. Contact allergy: the local lymph node assay for the prediction of hazard and risk. Clin Exp Dermatol. 2003;28:218–21.CrossRefPubMedGoogle Scholar
  71. 71.
    Ikarashi Y, Ohno K, Tsuchiya T, Nakamura A. Differences of draining lymph node cell proliferation among mice, rats and guinea pigs following exposure to metal allergens. Toxicology. 1992;76:283–92.CrossRefPubMedGoogle Scholar
  72. 72.
    Galbiati V, Mitjans M, Corsini E. Present and future of in vitro immunotoxicology in drug development. J Immunotoxicol. 2010;7:255–67.CrossRefPubMedGoogle Scholar
  73. 73.
    Gibbs MS, De BG, Mulder A, Mommaas AM, Ponec M. Melanosome capping of keratinocytes in pigmented reconstructed epidermis--effect of ultraviolet radiation and 3-isobutyl-1-methyl-xanthine on melanogenesis. Pigment Cell Res. 2000;13:458–66.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of DermatologyVU University Medical CentreAmsterdamThe Netherlands
  2. 2.Department of Oral Cell BiologyAcademic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and VU UniversityAmsterdamThe Netherlands

Personalised recommendations